Humacyte, Inc.

NASDAQ:HUMA

Biotechnology

Healthcare
$0.50 -3.35%

-$0.03 today

Market cap
$139.18M
Beta
2.46
P/E (TTM)
-1.9
EPS (TTM)
-$0.49
52W Low $0.55High $2.84

Volume 4.34M

Average 8.14M

Balance Sheet

Inspect the capital base behind the business.

Assets

$116.37M

FY 2025 · Annual

-15.6% YoY

Liabilities

$113.26M

FY 2025 · Annual

-40.6% YoY

Equity

$3.11M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents217.5M149.77M80.45M44.94M50.5M
Short-term Investments8M2.11M000
Net Receivables176K31K00441K
Inventory000013.59M
Other Current Assets02.3M2.83M2.92M3.27M
Total Current Assets229.34M154.21M83.28M47.86M67.8M
Property, Plant & Equipment (Net)57.19M50.09M44.1M38.55M47.69M
Goodwill00000
Intangible Assets00000
Long-term Investments0000209K
Tax Assets00000
Other Non-current Assets00841K51.46M672K
Total Non-current Assets57.19M50.09M44.95M90.01M48.57M
Total Assets286.53M204.3M128.22M137.87M116.37M
Account Payables2.09M1.6M6.49M4.49M5.4M
Short-term Debt08.57M000
Tax Payables173K0000
Deferred Revenue00000
Other Current Liabilities4.12M4.23M5.29M7.37M6.63M
Total Current Liabilities11.05M19.58M18.44M19.95M18.37M
Long-term Debt27.36M20.34M38.6M63.35M35.44M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities104.16M28.61M41.34M156.97M32.47M
Total Non-current Liabilities153.31M67.79M96.23M170.59M94.89M
Total Liabilities164.36M87.37M114.68M190.54M113.26M
Common Stock10K10K10K13K20K
Retained Earnings(414.57M)(426.54M)(537.31M)(686.02M)(726.85M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity122.17M116.93M13.55M(52.67M)3.11M
Total Debt51.18M50.07M57.45M16.54M64.85M
Net Debt(166.32M)(99.71M)(23M)(28.4M)14.35M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$48.5M
Receivables$434.0K
Inventory$9.9M
Other Current$4.7M
Total Current Assets$63.6M
PP&E (Net)$46.1M
Long-term Investments$209.0K
Other Non-current$672.0K
Total Non-current Assets$47.0M
Total Assets$110.6M

Analysis

Selected assets total $110.6M for Latest. The largest visible component is Cash & Equivalents at $48.5M, about 43.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
4Statement of changes in beneficial ownershipOct 7, 2026
3Initial statement of beneficial ownershipSep 28, 2026

How much cash does HUMA have?

Humacyte, Inc. (HUMA) reported $50.50M in cash and equivalents in fiscal 2025.

How much debt does HUMA carry?

Humacyte, Inc. (HUMA) reported $64.85M of total debt, with net debt of $14.35M.